Patients treated with monoclonal antibodies during COVID-19 delta surge had low rates of severe disease, Mayo Clinic study finds - Mayo Clinic News Network

Patients treated with monoclonal antibodies during COVID-19 delta surge had low rates of severe disease, Mayo Clinic study finds - Mayo Clinic News Network
Causes  - cover
Magazine
Avatar

Michaela B flipped this story into Causes 42d

Related articles